Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.660
-0.070 (-4.05%)
At close: Jun 26, 2026, 4:00 PM EDT
1.680
+0.020 (1.20%)
After-hours: Jun 26, 2026, 4:25 PM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $91.27 million as of June 26, 2026. Its market cap has decreased by -29.18% in one year.
Market Cap
91.27M
Enterprise Value
-52.37M
1-Year Change
-29.18%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $91.27M, a decrease of -97.21%. That is a compound annual growth rate of -47.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 91.27M | -11.34% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 100.55M |
| Verrica Pharmaceuticals | 97.06M |
| ProMIS Neurosciences | 95.86M |
| PolyPid | 95.68M |
| Anixa Biosciences | 93.90M |
| Rani Therapeutics Holdings | 93.53M |
| Inovio Pharmaceuticals | 92.97M |
| Aardvark Therapeutics | 92.28M |